In diabetic rats, puerarin also reduced the myocardial infarction area via a reduction of oxidized stress, an inhibition of NF‐κB inflammation, and a potential rise in vascular endothelial growth factor A (VEGFA) mediated angiogenesis, subsequently greatly improving cardiac performance.42 This evidence concerns the gene VEGFA and myocardial infarction.